Vaccination, Eligibility and Vaccine Finder

COVID-19 VACCINE ELIGIBILITY & mRNA SCHEDULE, PROOF of VACCINATION and VACCINE FINDER

All people in Manitoba aged 6 months and older are eligible for COVID-19 vaccination. The current COVID-19 vaccine that is available and will be provided in Manitoba is the updated formulation that protects against the XBB.1.5 strain of the COVID-19 virus.

Vaccines are the best defense against the COVID-19 virus. Individuals are encouraged to get vaccinated as soon as they are eligible and ensure they receive all the doses recommended for the best protection.

The vaccine is available from medical clinics, pharmacies and other locations. Use the Vaccine Finder to find a convenient location. You can make your vaccine appointment at some sites online or by calling 1-844-626-8222.

On this page:

XBB.1.5 Vaccine Eligibility
Vaccine Eligibility for Children aged 6 months to 4 years
Vaccine Eligibility for Individuals aged 5 years and Older
Vaccine Eligibility for Infants, Children, Youth and Adults who are Moderately to Severely Immunocompromised
Immunization after a COVID-19 infection
Canadian Proof of Vaccination Credential and Immunization records
Vaccine finder

XBB.1.5 Vaccine Eligibility

Updated formulations of the COVID-19 mRNA vaccines have been developed to protect against the XBB.1.5 strain of the COVID-19 virus. They have been approved for use in:

Individuals aged 6 months and older who have never received a COVID-19 vaccine.
Individuals aged 6 months and older who have already received a COVID-19 vaccine and need one or more additional doses to complete their primary series.
Individuals aged 6 months and older who have completed a primary series with COVID-19 vaccines and are recommended to receive an additional dose for fall 2023.

Both brands of COVID-19 mRNA vaccine (Moderna and Pfizer) are effective for preventing severe disease from COVID-19. Current data do not show a product-specific difference in the risks of myocarditis and/or pericarditis after a dose of an updated formulation of mRNA COVID-19 vaccine. The vaccine available to you is the best option and it is recommended you get vaccinated with the XBB.1.5. formulation at your earliest opportunity. All Manitobans aged 6 months and older are recommended to receive a dose of the new formulation of COVID-19 vaccine if it has been at least 6 months from the previous COVID-19 vaccine dose or known SARS-CoV-2 infection (whichever is later). For those with a complete primary series, the recommended interval is 6 months, but you may receive a dose of XBB.1.5 formulation if it has been at least 3 months from any previous COVID-19 vaccine formulation or known infection.

Please note there may be a decreased immune response to the vaccine when provided sooner than the recommended 6-month period.

Vaccine Eligibility for Children aged 6 months to 4 years

Children 6 months to 4 years of age who have never been vaccinated or have not completed a primary series against COVID-19 are eligible to receive two or three doses depending on the vaccine product. Children must be at least six months of age at the time of their immunization appointment.

There are two products authorized for children 6 months to 4 years:

Moderna: The primary series consists of 2 doses. The minimum interval between the first and second dose is four weeks.
Pfizer: The primary series consists of 3 doses. The interval between the first and second dose is three weeks. The minimal interval between the second and third dose is eight weeks.

Individuals who started their primary series with the original monovalent or bivalent vaccines can complete their primary series with the updated XBB.1.5 formulation. Regardless of which product was used to start a primary series, the previous dose(s) should be counted, and the series need not be restarted.

Beginning in the fall of 2023 for those previously vaccinated against COVID-19 (completed primary series), individuals aged 6 months and older are recommended to receive a dose of the new formulation of COVID-19 vaccine if it has been at least 6 months from the previous COVID-19 vaccine dose or known SARS-CoV-2 infection (whichever is later). The recommended interval is 6 months, but you may receive a dose of XBB.1.5 formulation if it has been at least 3 months from any previous COVID-19 vaccine formulation or known infection.

Approved COVID-19 mRNA vaccine for primary series

Time between doses of primary series/# of doses

If Primary Series Complete, time between last dose received and additional dose

Approved COVID-19 mRNA vaccines for additional doses for fall 2023

Infants and children aged
6 months to 4 years

Moderna/Spikevax™ XBB.1.5 (25mcg)

Pfizer/Comirnaty™ XBB.1.5 (3mcg)

Moderna: minimum 4 weeks/ 2 doses

Pfizer: 3 weeks between first and second dose; minimum 8 weeks between second and third/ 3 doses

3-6 months (6 months is recommended)

Moderna/Spikevax™ XBB.1.5 (25mcg)

Pfizer/Comirnaty™ XBB.1.5 (3mcg)

For more information on the National Advisory Committee on Immunization (NACI) recommendations, please go to the Canadian Immunization Guide.

Vaccine Eligibility for Individuals aged 5 years and Older

Individuals 5 years and older who have never been vaccinated against COVID-19 or have not completed a primary series are eligible to receive one dose of the new XBB.1.5 formulation. Regardless of which product was used to start a primary series, the previous dose(s) should be counted and the series need not be restarted.

Beginning in the fall of 2023 for those previously vaccinated against COVID-19 (primary series completed), individuals aged 6 months and older are recommended to receive a dose of the new formulation of COVID-19 vaccine if it has been at least 6 months from the previous COVID-19 vaccine dose or known SARS-CoV-2 infection (whichever is later). The recommended interval is 6 months, but you may receive a dose of XBB.1.5 formulation if it has been at least 3 months from any previous COVID-19 vaccine formulation or known infection.

Immunization is particularly important for those at increased risk of COVID-19 infection or severe disease, for example:

Adults 65 years of age or older
Residents of long-term care homes and other congregate living settings
Individuals with underlying medical conditions that place them at higher risk of severe COVID-19
Individuals who are pregnant
Individuals in or from First Nations, Métis and Inuit communities
Members of racialized and other equity-deserving communities
People who provide essential community services

Approved COVID-19 mRNA vaccine for primary series

Number of Doses

If Primary Series Complete, time between last dose received and additional dose

Approved COVID-19 mRNA vaccines for additional doses for fall 2023

Individuals aged
5 years to 11 years

Moderna/Spikevax™ XBB.1.5 (25mcg)

Pfizer/Comirnaty™ XBB.1.5 (10mcg)

1 dose

3-6 months (6 months is recommended)

Moderna/Spikevax™ XBB.1.5 (25mcg)

Pfizer/Comirnaty™ XBB.1.5 (10mcg)

Individuals aged
12 years and older

Moderna/Spikevax™ XBB.1.5 (50mcg)

Pfizer/Comirnaty™ XBB.1.5 (30mcg)

1 dose

3-6 months (6 months is recommended)

Moderna/Spikevax™ XBB.1.5 (50mcg)

Pfizer/Comirnaty™ XBB.1.5 (30mcg)

Novavax/Nuvaxovid™, if available, is a different type of COVID-19 vaccine that may be offered to adults 12 years and older who are unable or unwilling to receive a COVID-19 mRNA vaccine.

For more information on the National Advisory Committee on Immunization (NACI) recommendations, please go to the Canadian Immunization Guide

Vaccine Eligibility for Infants, Children, Youth and Adults who are Moderately to Severely Immunocompromised

For the purposes of COVID-19 vaccine recommendations, the following individuals are considered moderately to severely immunocompromised due to a medical condition and/or treatment:

are receiving active chemotherapy (or immunotherapy) for cancer;
have received a solid organ transplant and are currently receiving chemotherapy or other immunosuppressive therapy;
were born with moderate or severe dysfunction of their immune system;
are living with untreated or advanced HIV-AIDS; or
are taking certain medications that severely affect the immune system.
The following people should talk to their doctor to see whether they are considered to be immunocompromised:
receiving hemodialysis or peritoneal dialysis;
are on the list to receive a solid organ transplant; or
have a ventricular assist device (VAD).

The COVID-19 mRNA vaccines are the preferentially recommended COVID-19 vaccines. Your health care provider may recommend a different immunization schedule for you based on a review of your medical history and individual circumstances.

If not previously immunized or if primary series is not completed against COVID-19:

Individuals six months to four years of age who are moderately to severely immunocompromised are eligible to receive three doses of the Moderna/Spikevax™ vaccine or four doses of the Pfizer/Comirnaty™ vaccine. The Moderna vaccine is preferred due to quicker protection from a three-dose series.
Individuals five years of age and older who are moderately to severely immunocompromised are recommended to receive three doses of COVID-19 vaccine. The recommended interval between doses is four to eight weeks.
Individuals who started their primary series with the original monovalent or bivalent vaccines can complete their primary series with the updated XBB.1.5 formulation. Regardless of which product was used to start a primary series, the previous dose(s) should be counted and the series need not be restarted.

If having previously completed a COVID-19 vaccine primary series:

Individuals six months of age and older who are moderately to severely immunocompromised are recommended to receive a dose of the updated XBB.1.5 formulation in the fall of 2023. The recommended interval is 6 months, but you may receive a dose of XBB.1.5 formulation if it has been at least 3 months from any previous COVID-19 vaccine formulation or known infection.

	Approved COVID-19 mRNA vaccine for primary series	Immunosuppressed: Time between doses of primary series/# of doses	If Primary Series Complete, time between last dose received and additional dose	Approved COVID-19 mRNA vaccines for additional doses for fall 2023
Infants and children aged 6 months to 4 years	Moderna/Spikevax™ XBB.1.5 (25mcg) or Pfizer/Comirnaty™ XBB.1.5 (3mcg)	+Moderna: 4 to 8 weeks between each dose/3 doses Pfizer: 4 to 8 weeks between each dose/4 doses	3-6 months (6 months is recommended)	Moderna/Spikevax™ XBB.1.5 (25mcg) or Pfizer/Comirnaty™ XBB.1.5 (3mcg)
Individuals aged 5 years to 11 years	Moderna/Spikevax™ XBB.1.5 (25mcg) or Pfizer/Comirnaty™ XBB.1.5 (10mcg)	4 to 8 weeks between each dose/3 doses	3-6 months (6 months is recommended)	Moderna/Spikevax™ XBB.1.5 (25mcg) or Pfizer/Comirnaty™ XBB.1.5 (10mcg)
Individuals aged 12 years and older	Moderna/Spikevax™ XBB.1.5 (50mcg) or Pfizer/Comirnaty™ XBB.1.5 (30mcg)	4 to 8 weeks between each dose/3 doses	3-6 months (6 months is recommended)	Moderna/Spikevax™ XBB.1.5 (50mcg) or Pfizer/Comirnaty™ XBB.1.5 (30mcg)

+ Moderna/Spikevax™ is the recommended mRNA vaccine for Immunocompromised Infants and children 6 months to 4 years.

Immunization after a COVID-19 infection

It is recommended to wait six months before getting your next dose of COVID-19 vaccine after a known SARS-CoV-2 infection. The recommended interval is 6 months, but you may receive a dose of XBB.1.5 formulation if it has been at least 3 months from any previous COVID-19 vaccine formulation or known infection.

Recommendations may be different if you are moderately to severely immunocompromised or not previously vaccinated. Please speak to your health care provider to get the best advice on when to get your next vaccine dose after a COVID-19 infection.

For more information on NACI's recommendation on interval between infection and getting your next COVID-19 vaccine dose, please visit: COVID-19 vaccine: Canadian Immunization Guide - Canada.ca.

How to Report your COVID-19 Vaccine and Update your Immunization Records

If you received a COVID-19 vaccine outside of Manitoba, you should report them so your Manitoba immunization record is up to date. In order to do this, you will need proof of immunization from the jurisdiction where you received your vaccine. Once you have your vaccination record that needs to be added, please use this online form to submit it, and your information will be updated once your immunization record is validated. You will be notified once your immunization record is updated. After your information has been updated, you can request your immunization record online.

The e-form process will make it faster and easier to make changes to your vaccination record. It will also help your primary care physician and our public health teams to view your full immunization history. Alternatively, people can call 1-844-MAN-VACC (1-844-626-8222) and follow the call centre prompts to get the update process started.

Immunization Records

In order to show your immunization status, residents of Manitoba can request a Canadian Proof of Vaccination Credential (PVC) (valid throughout Canada and internationally). As of March 1, 2022, Manitoba's proof of vaccination requirement is no longer mandatory.

Canadian Proof of Vaccination Credential (PVC)
Immunization Records

Canadian Proof of Vaccination Credential (PVC)

The Canadian COVID-19 Proof of Vaccination Credential (PVC) is a secure and reliable way to show your proof of COVID-19 vaccination history. The only medical information contained in this document is related to your COVID-19 vaccination history. The PVC, and associated QR code, contains your name, date of birth, date of immunization, brand of vaccine received and lot number. If your information is scanned by a verifier app it will be subject to open data collection.

The PVC can be used for travel within Canada and internationally and is a recognized and trusted document with international partners. It is important to confirm the immunization requirements for your travel destination and any stops along the way before departing to confirm what type of proof is accepted.

Request Your PVC

You can request your PVC online at immunizationcard.manitoba.ca or through the Manitoba Immunization Card app available in the Apple App Store or on Google Play. You can also call the province's call centre at 1 844 MAN VACC (1 844 626 8222) for more information about the process. Your PVC will contain any international COVID-19 vaccines you received if they are part of Health Canada's accepted list of World Health Organization (WHO) approved COVID-19 vaccines. The list of WHO approved COVID-19 vaccines can be found at: COVID-19 Vaccines with WHO Emergency Use Listing | WHO - Prequalification of Medical Products (IVDs, Medicines, Vaccines and Immunization Devices, Vector Control). If you received a vaccine that is not on the accepted list, it may still appear on the PVC but with limited information.

The PVC is available digitally on your smart phone/device or you can select to receive it by email and you can then print a hard copy of the PDF. If you would like to have your PVC available on multiple devices, you must request the PVC on each individual device. The app only stores the information for your PVC while you are logged in. Once logged out, the app will erase your PVC. You will have to request it again the next time you log in. It is NOT available as a wallet certificate at this time.

The PVC follows the SMART Health Card standard. It provides a safe and secure way to share limited information about your COVID-19 vaccination history. Any scanner that has the ability to read a SMART Health Card QR code will be able to read the QR code on your PVC. You can keep a digital copy of your proof of vaccination on any smart phone/device.

More information on the PVC and SMART Health Cards is available at canada.ca/en/public-health/services/diseases/coronavirus-disease-covid-19/vaccines/vaccine-proof.html

If you are unable to access your PVC, please submit a request at https://forms.gov.mb.ca/immunization-update-request/ or call 1-844-626-8222.

Immunization Records (All vaccinations)

An immunization record is a personal medical record used by the provincial health care system that identifies the vaccinations that you have received that were recorded by health care providers in Manitoba.

Manitobans can access their own COVID-19 immunization records online, which show the dates you received COVID-19 vaccines and the type of vaccines received. It is helpful to know when you received your previous doses of COVID-19 vaccine and the type of vaccine you received. If you do not recall this information and you have a Manitoba health card, you can locate it at: sharedhealthmb.ca/covid19/test-results/. If your immunization record is incomplete or incorrect, or you received a COVID-19 vaccination outside of Manitoba, you can have your file updated by completing and submitting this e-form.

For a copy of your full immunization record, please contact your local public health office. Further information on immunization records can be found at: Your Immunization Record Matters | Communicable Disease Control | Public Health | Manitoba Health | Province of Manitoba (gov.mb.ca)

Please be aware that your immunization record, including the COVID-19 immunization record, may not be an acceptable form of proof of vaccination for the purposes of travel. It is recommended to obtain your Canadian Proof of Vaccination Credential (PVC) for travel purposes.

NOTE: All Manitobans are reminded to be aware of phishing scams. Manitobans are strongly advised to not provide information to any non-Government of Manitoba website or application.

Other important information

For information additional information on vaccine risk and intended benefits, please refer to the Provincial factsheets

Canada's National Advisory Committee on Immunization (NACI) makes COVID-19 vaccine specific recommendations for people of all ages. These recommendations and guidance from NACI are available here.

Vaccine finder

To book your flu, COVID-19, and pneumococcal (Pneu-P-23) vaccine at a site near you, use the Vaccine Finder Map below to find a convenient location with available vaccines. The current COVID-19 vaccine that is available and will be provided in Manitoba is the updated formulation that protects against the XBB.1.5 strain of the COVID-19 virus. Both brands of COVID-19 mRNA vaccine (Moderna and Pfizer) are effective for preventing severe disease from COVID-19. Current data do not show a product-specific difference in the risks of myocarditis and/or pericarditis after a dose of an updated formulation of mRNA COVID-19 vaccine. The vaccine available to you is the best option and it is recommended you get vaccinated with the XBB.1.5 formulation at your earliest opportunity. You can use the contact information provided on the map to make your appointment directly with a pharmacy or medical clinic. Note: Pharmacies are only authorized to provide COVID-19 and flu vaccines to individuals aged 2 years and above.

ONLINE - PUBLIC HEALTH Appointment Clinics only
You can create an account on Manitoba Vaccination Services through the Petal System available at https://patient.petal-health.com/login?groupId=6032 and follow the prompts to book the vaccine appointment online for an appointment based public health clinic.

BY PHONE
If you are unable to book your appointment for a public health clinic through the Petal System or need assistance with booking, you can call 1 844 MAN VACC (1 844 626 8222) toll-free Monday to Friday from 9 a.m. to 5 p.m to book an appointment at a public health clinic only.

For appointments at pharmacies or medical clinics, you will need to contact those locations directly as indicated for that location in the Vaccine Finder Map

View the map in a separate window

For Immunization Providers:

Please remember to keep how your location appears on the map current by visiting https://forms.office.com/r/fZh8GGdJgQ.

Data from this source will be used to update the map daily from Monday to Friday.

If you notice an error in the information presented on the map, please email COVID@gov.mb.ca* and remember to include your client ID in any communications.

*This email address is for communications from immunization providers only. Emails from members of the public will not be returned. Please direct any of your questions or concerns to Ask Health by filling out the following form: https://forms.gov.mb.ca/Ask_Health/

Close Window